Home WebinarsArtificial Intelligence-Based Screening and Selection of Co-Formers for Co-Crystallization

Artificial Intelligence-Based Screening and Selection of Co-Formers for Co-Crystallization

WEBINAR

70% of APIs under development are poorly water soluble which increases the risk of them failing during formulation. Co-crystallization is a rapidly growing technique used to tackle solubility challenges. However, it is challenging and resource intensive to find new co-crystals experimentally.

In recent years, several approaches have been developed to screen for co-crystals computationally. We developed mPredict™, a co-crystal prediction tool with quantum chemistry, statistical thermodynamics, and AI. It predicts co-crystal formation and, hence, optimal co-formers for your API. Besides being a strong improvement over physical modeling, it is also three times faster than random digital screening.

In this webinar, you will learn:

That co-crystallization is rapidly growing as a technique to tackle solubility challenges
About the challenges of co-crystallization and ways to overcome them
What are the key technical considerations to build an AI based co-former screening tool
About the advantages of using our cutting edge mPredict™ co-crystal prediction service

Speakers

Mitali Bhagwat

{hcompany}

Strategic Product Manager – Excipients Solid Application

Mitali has a master's degree in pharmaceutical sciences with several years of work experience in the pharma industry on generic product development and filing. With a degree in intellectual property, she previously worked on developing IP strategies. After completing her MBA in international management and consulting in the pharma industry, she now works at {hcompany} as a strategic product manager. Her responsibility lies in the field of excipients used for solid formulation drug development wherein she is leading the digital strategy with its flagship product mPredict™.

Rimson Muara Jaya

{hcompany}

Customer Application Expert SEATWO

Rimson is a technical application expert, specializing in small to large molecules. Rimson holds a pharmacist's degree and a master's in business administration. He has more than 10 years of extensive experience in the pharmaceutical industry, with a strong focus on project management, production, and GMP assurance for various small molecule pharmaceutical dosage forms.